Hypertensive emergency: Difference between revisions

(Created page with "==Diagnosis== Need for acute BP reduction d/t end-organ dysfunction Generally need ≥180/120 mmHg, but usually >220/130 BRAIN- HTN encephelopathy, seizure, ICH, ischemic ...")
 
 
(119 intermediate revisions by 20 users not shown)
Line 1: Line 1:
==Diagnosis==
''High blood pressure without symptoms is NOT hypertensive emergency (see [[asymptomatic hypertension]])''


==Background==
*Definition: end-organ damage due to hypertension
**Blood pressure is generally >180/120 (usually > 220/130), but presence of end-organ damage defines disease (not absolute blood pressure number)
**1%-6% of all ED patients will present with severe hypertension, but less than half of those will have target organ damage<ref>Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. doi:10.1161/01.HYP.0000107251.49515.c2</ref>


Need for acute BP reduction d/t end-organ dysfunction
===Etiology===
*Idiopathic
*[[Sympathomimetic]] drug use
*[[Preeclampsia]]
*Acute [[glomerulonephritis]]


Generally need ≥180/120 mmHg, but usually >220/130
===Prehospital===
*Prehospital BP measurements should be considered reliable<ref>Cienki JJ, DeLuca LA. Agreement between emergency medical services and expert blood pressure measurements. J. Emerg Med. 2012;43(1):64-68.</ref>
*Acute lowering of BP is not typically recommended
*Focus on ABCs (assess need for [[intubation]] or [[BiPAP|respiratory support]])
*Provide care of treatable etiologies
**[[CHF]]
**[[Respiratory failure]] from [[pulmonary edema]]
**Acute pain


==Clinical Features==
'''End-Organ Dysfunction<ref>Levy PD. Hypertensive Emergencies — On the Cutting Edge. EMCREG - International. 2011. 19-26.</ref>'''
*[[Acute kidney injury]]
**Often with microscopic hematuria
*[[Pulmonary edema]]
*Type-II [[myocardial infarction]]
*[[Hypertensive encephalopathy]]
**Visual disturbances
**[[Seizure]]
**Delirium


BRAIN- HTN encephelopathy, seizure, ICH, ischemic stroke
==Differential Diagnosis==
{{Hypertension DDX}}


HEART- AMI, CHF/LV failure/pulm edema, Aortic Dissection
==Evaluation==
===Workup===
''Consider any of the following based on the patient's clinical presentation''<ref>2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-1938.</ref>
*CBC with peripheral smear- assess for microangiopathic hemolytic anemia
*Chem 8 - assess renal failure and possible secondary causes
*[[Troponin|Cardiac enzymes]]
*[[Urinalysis]] - Assess renal failure, glomerulonephritis, preeclampsia
*[[ECG]] - [[LVH]], [[myocardial ischemia|ischemia]]
*[[Ultrasound]] - evaluate for aortic dissection, bladder outlet obstruction, or depressed myocardial function
*[[Fundoscopic Exam]] - evaluate for hypertensive retinopathy or papilledema
*[[CXR]] - evaluate for pulmonary edema or dissection
*[[CT head]] - in hypertensive encephalopathy, may not show acute hemorrhage or other acute pathology
**Hypertensive encephalopathy is thought to be secondary to alteration in cerebral auto-regulation leading to [[posterior reversible encephalopathy syndrome]] (now called reversible posterior leukoencephalopathy). Most patients will show changes on MRI, although this is not necessarily indicated in the emergency department.


EYES- Retinal hemorrhages, exudates, or papilledema
===Diagnosis===
*Must have evidence of end-organ dysfunction
**''High blood pressure without symptoms is NOT hypertensive emergency (see [[asymptomatic hypertension]])''
**''Symptoms such as headache, epistaxis and dizziness are not evidence of acute end-organ damage and they are not indication for acute BP reduction''


KIDNEYS- Acute Renal Failure
==Management==
'''High blood pressure without end organ damage is NOT hypertensive emergency (see [[asymptomatic hypertension]])'''
*Goal: Lower mean arterial or systolic pressure by no more than 10-20% in the first hour<ref>Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis. 2006;48(5):316-325. doi:10.1016/j.pcad.2006.02.004</ref>
**Then lower by an additional 5-15% over the next 23 hours for no more than 25% in the first 24 hours
**Exception is [[aortic dissection]] which requires rapid reduction to systolic BP to 100-120 mmHg
*Be careful of lowering BP in patients with [[CVA]]


(Pre)Eclampsia
===By Drug===
{| class="wikitable"
|-
| '''Drug'''
| '''Dose'''
| '''Mechanism'''
| '''Pros'''
| '''Cons'''
| '''Notes'''
|-
| [[Nitroprusside]]
|


Catecholamine-induced HTN
0.3-0.5 mcg/kg/min IV initial infusion


Increase by 0.5 mcg/kg/min up to 2mcg/kg/min


CAUTION: Ischemic stroke and tPA candidates


| Arterial > venodilator
|
1. Very effective


==Treatment ==
2. Immediate onset/offset


|
1. Cyanide Toxicity


GOAL: Reduction of MAP by 10-15% in first 1-2 hrs
2. Coronary steal?


(no more than 25%, except in dissection)
3. Increased HR


MAP= (2/3)DBP +(1/3)SBP
|
1. Avoid in liver/renal failure


2. Avoid with increased ICP


DRUGSNitroprusside
3. Avoid in pregnancy


mech - arteriolar and venous dilation
|-
| [[Nitroglycerin]]
| Start 5-100 mcg/min
| Veno>arteriodilation
|
1. Rapid on/offset


pros  - very effective rapid on/offset
2. Increases coronary flow


cons  - cyanide toxicity, caution in renal insufficiency
| Causes tachycardia
|
Drug of choice in patients with cardiac ischemia,


        - potential hypotension and end-organ hypoperfusion
LV dysfunction, or pulmonary edema


        - tissue necrosis if extravasation
|-
| [[Labetalol]]
|
20-80mg IV bolus q10 min '''OR'''


        - increases intracranial pressure
0.5-2 mg/min IV infusion or


dose - 0.5-8 mcg/kg/min
200mg to 400mg PO BID


| Beta>α-blocker
|
1. No change in HR, cerebral flow
2. Rapid onset


Nitroglycerin
|
Avoid in COPD, CHF and heart block


mech - venodilation at low doses, arteiolar at high doses
|
1. Consider in ACS
2. Consider in ischemic CVA


pros - usually readily available in the ED
|-
| [[Esmolol]]
|
Load 250-500 mcg/kg over 2min


        - rapid on/offset
Infuse 50 mcg/kg/min over 4min


        - improves coronary collateral flow
- if ineffective repeat load, increase infusion rate by &nbsp;50mcg/kg/min up to 300mcg/kg/min


        - good for CHF, angina; bad for HTN crisis
| Beta selective
| Rapid on/offset
|
Avoid in COPD, CHF


cons- tachycardia, tolerance
bradycardia


dose - 10-250 mcg/min
|
Consider in ACS


|-
| [[Nicardipine]]
|
Start 5mg/h


Labetalol
If ineffective after 15min increased in 2.5mg/hr interval up to 15mg/hr


mech- alpha/beta blockers (beta>alpha), vasoldilation
| Decreases PVR<br/><br/>
| Good for intracranial pathology
| Slower onset/offset
| Avoid in CHF, ACS
|-
| [[Phentolamine]]
|
5-15mg IV bolus q5-15min '''OR'''


pros- no change in HR
0.2-0.5mg/min IV infusion


cons- not for copd, those with beta-blocker intolerance
| α-blocker
|
|
| Used for catecholamine-induced hypertension
|-
| [[Enalaprilat]]
| Bolus 1.25mg over 5min q6hr, titrate at 30min intervals to max of 5mg q6hr
| Decreases HR, SV, systemic arterial pressure
| Does not impair cerebral flow
| Variable response
|
1. Used in patients at risk for cerebral hypotension, CHF


dose - if bolused, 20mg, 40-80mg q10min (max 300mg)
2. Avoid in pregnancy


2 mg/min infusion
|-
| [[Clonidine]]
|
0.1 - 0.3 mg PO q12 scheduled; For hypertensive emergency, 0.2 mg x1, then 0.1 mg q1 hr PRN, max 0.6 mg total


| α-2 agonist, BP effects within 30-60 min after PO dose
|
|
| Reduced CNS sympathetic flow, decreasing SVR, HR, BP; no renal blood flow changes; tolerance/tachyphylaxis develop quickly


Hydralazine


mech- arteriolar dilator
|-
| [[Hydralazine]]
|
10 - 20 mg slow IV/IM bolus q4-6 hr PRN, max 40 mg/dose


pros- obs like it for eclampsia
| Peripheral vasodilator, with fall in BP beginning within 30 min, lasting 2-4 hrs
|
|
| Decrease in DBP > SBP; has increased HR, stroke volume and cardiac outpt; preferential vasodilation > venodilation


cons- reflex tachycardia, unpredictable bp effect, sometimes takes hours for effect


dose - 10mg q20min
|}


0.5-1 mg/min IV infusion
===By Disease===


====[[Aortic Dissection]]====


Nicardapine
*Rapidly reduce sys BP to 100-120; HR 60-80 within 20min
*Adequate analgesia will decrease sympathetic drive and assist with BP and HR control
*Avoid volume depletion
*Prevent reflex tachycardia
**Labetalol alone
**Nitroprusside or nicardipine AFTER metoprolol or esmolol


mech- CCB (dihydropyridine); decreased PVR > cardiac
====[[Pulmonary Edema]]====
*Reduce BP by 20-30%
*Promote diuresis AFTER vasodilation


pros- rapid onset, neurosrugeons like it
====[[ACS]]====


cons- slower offset than NTP or NTG
*No more than 20-30% reduction for SBP >160
*Consider NTG, beta-blocker


dose - 5 mg/hr, max 15mg/hr
====[[Cocaine]]/[[Amphetamine]] Toxicitiy====


*[[Benzos]]
*Mixed α + B blockade
**Phentolamine '''OR''' nitroprusside AND β-blocker


ACE-i (enalaprilat)
====[[Renal Failure]]====


no well studied
*Reduce BP by no more than 20%
*Avoid nitroprusside (renal metabolism)
*Labetalol or nicardipine


dose - 1.25 mg q6 hr
====[[Eclampsia]]/[[Pre-eclampsia]]====


*Goal BP <160/110
*Labetalol or nicardipine
*Magnesium


Fenlodopam
====[[Hypertensive emergency]]====
*Decrease MAP by 15-20%
**Avoid overly aggressive lowering
*[[Nicardipine]] or [[labetalol]]


mech- peripheral dopamine agonist--->ateriolar dilation
====[[CVA]]====


pros- rapid on/offset, renal insufficiency
*[[SAH]]
**See [[Subarachnoid Hemorrhage (SAH)]]
*[[ICH]]
*See [[ICH#Guidelines|current guidelines]] for best practice
**[[Labetalol]] or [[Nicardipine]] or [[Esmolol]]
*[[Stroke (Main)|Ischemic]]
**If thrombolytic treatment is planned then goal systolic blood pressure 185 mm Hg and diastolic blood pressure 110 mm Hg<ref>Acute Stroke Practice Guidelines for Inpatient Management of Ischemic
Stroke and Transient Ischemic Attack (TIA) https://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/documents/downloadable/ucm_309996.pdf</ref>
**If no thrombolytics then consider blood pressure control if SBP >220 mmHg or DBP >120 mmgHg
**[[Labetalol]] or [[Nicardipine]] are both effective and safe


cons- $$$
====[[Pheochromocytoma]]====
*Phentolamine '''OR''' (nitroprusside AND β-blocker)


dose - 0.1 µg/kg/min
==Disposition==
*Admit
**Patients receiving titratable antihypertensive therapies will likely require admission to critical care unit


==See Also==
*[[Hypertension (main)]]
*[[Asymptomatic hypertension]]
*[[IV nitroglycerine alternatives]]


Phentolamine
==External Links==
*[http://www.emdocs.net/hypertensive-crisis-pearls-and-pitfalls-for-the-ed-physician/ emDocs - Hypertensive Emergency: Pearls and Pitfalls for the ED Physician]
*[https://emcrit.org/ibcc/hypertensive-emergency/ EMCrit - Hypertensive Emergency]


mech- alpha blocker
==References==
<references/>


pros- esp, pheochromcytoma (catecholamine-induced)
[[Category:Cardiology]]
 
cons- hard to find, waiting for pharmacy
 
dose - 5 to 10 mg every 5 to 15 minutes
 
0.2-5 mg/min IV infusion
 
 
Esmolol
 
mech- beta blocker
 
pros- ultra short-acting, dissection
 
cons- not for copd, those with beta-blocker intolerance
 
dose - Loading dose: 250-500 mcg/kg infused over 1 min
 
Maintenance infusion: 50 mcg/kg/min over 4 min
 
 
==Organ Specific==
 
 
HTN Encephalopathy
 
    Controlled redxn of BP over 1h; never < 110 diastolic
 
          Labetolol, nicardipine, fenoldopam; nitroprusside of diastolic > 140
 
 
Stroke
 
    10-15% reduction of MAP; diastolic not < 110
 
    lower to 185/110 in ischemic stroke to meet t-PA criteria
 
          Labetolol, nicardipine, nitroprusside as above
 
 
Acute Aortic Dissection
 
    Rapid redxn of BP, systolic bp 100-120; HR 60-80 within 20mins
 
    Prevent reflex tachycardia
 
          Nitroprusside, fenoldopam, nicardipine with metoprolol or esmolol; labetolol alone
 
 
ACS and Pulmonary Edema
 
    Nitroglycerin
 
 
Eslampsia/Pre-eclampsia
 
    Labetolol, nicardipine or IV hydralazine
 
    Magnesium
 
 
Cocaine and Amphetamine Toxicitiy
 
    BDZs
 
    Mixed alpha + B blockade: phentolamine or nitroprusside plus beta blocker
 
 
Pheochromocytoma
 
    Phentolamine or nitroprusside plus beta blocker
 
 
ARF
 
    Fenoldopam, nicardipine; nitroprusside risk cyanide toxicity (renal metabolism)
 
 
 
==Source ==
 
 
Adapted from Bessen, Bresler (ACEP '09)
 
 
 
 
[[Category:Cards]]

Latest revision as of 20:09, 17 April 2024

High blood pressure without symptoms is NOT hypertensive emergency (see asymptomatic hypertension)

Background

  • Definition: end-organ damage due to hypertension
    • Blood pressure is generally >180/120 (usually > 220/130), but presence of end-organ damage defines disease (not absolute blood pressure number)
    • 1%-6% of all ED patients will present with severe hypertension, but less than half of those will have target organ damage[1]

Etiology

Prehospital

Clinical Features

End-Organ Dysfunction[3]

Differential Diagnosis

Hypertension

Evaluation

Workup

Consider any of the following based on the patient's clinical presentation[4]

  • CBC with peripheral smear- assess for microangiopathic hemolytic anemia
  • Chem 8 - assess renal failure and possible secondary causes
  • Cardiac enzymes
  • Urinalysis - Assess renal failure, glomerulonephritis, preeclampsia
  • ECG - LVH, ischemia
  • Ultrasound - evaluate for aortic dissection, bladder outlet obstruction, or depressed myocardial function
  • Fundoscopic Exam - evaluate for hypertensive retinopathy or papilledema
  • CXR - evaluate for pulmonary edema or dissection
  • CT head - in hypertensive encephalopathy, may not show acute hemorrhage or other acute pathology
    • Hypertensive encephalopathy is thought to be secondary to alteration in cerebral auto-regulation leading to posterior reversible encephalopathy syndrome (now called reversible posterior leukoencephalopathy). Most patients will show changes on MRI, although this is not necessarily indicated in the emergency department.

Diagnosis

  • Must have evidence of end-organ dysfunction
    • High blood pressure without symptoms is NOT hypertensive emergency (see asymptomatic hypertension)
    • Symptoms such as headache, epistaxis and dizziness are not evidence of acute end-organ damage and they are not indication for acute BP reduction

Management

High blood pressure without end organ damage is NOT hypertensive emergency (see asymptomatic hypertension)

  • Goal: Lower mean arterial or systolic pressure by no more than 10-20% in the first hour[5]
    • Then lower by an additional 5-15% over the next 23 hours for no more than 25% in the first 24 hours
    • Exception is aortic dissection which requires rapid reduction to systolic BP to 100-120 mmHg
  • Be careful of lowering BP in patients with CVA

By Drug

Drug Dose Mechanism Pros Cons Notes
Nitroprusside

0.3-0.5 mcg/kg/min IV initial infusion

Increase by 0.5 mcg/kg/min up to 2mcg/kg/min


Arterial > venodilator

1. Very effective

2. Immediate onset/offset

1. Cyanide Toxicity

2. Coronary steal?

3. Increased HR

1. Avoid in liver/renal failure

2. Avoid with increased ICP

3. Avoid in pregnancy

Nitroglycerin Start 5-100 mcg/min Veno>arteriodilation

1. Rapid on/offset

2. Increases coronary flow

Causes tachycardia

Drug of choice in patients with cardiac ischemia,

LV dysfunction, or pulmonary edema

Labetalol

20-80mg IV bolus q10 min OR

0.5-2 mg/min IV infusion or

200mg to 400mg PO BID

Beta>α-blocker

1. No change in HR, cerebral flow 2. Rapid onset

Avoid in COPD, CHF and heart block

1. Consider in ACS 2. Consider in ischemic CVA

Esmolol

Load 250-500 mcg/kg over 2min

Infuse 50 mcg/kg/min over 4min

- if ineffective repeat load, increase infusion rate by  50mcg/kg/min up to 300mcg/kg/min

Beta selective Rapid on/offset

Avoid in COPD, CHF

bradycardia

Consider in ACS

Nicardipine

Start 5mg/h

If ineffective after 15min increased in 2.5mg/hr interval up to 15mg/hr

Decreases PVR

Good for intracranial pathology Slower onset/offset Avoid in CHF, ACS
Phentolamine

5-15mg IV bolus q5-15min OR

0.2-0.5mg/min IV infusion

α-blocker Used for catecholamine-induced hypertension
Enalaprilat Bolus 1.25mg over 5min q6hr, titrate at 30min intervals to max of 5mg q6hr Decreases HR, SV, systemic arterial pressure Does not impair cerebral flow Variable response

1. Used in patients at risk for cerebral hypotension, CHF

2. Avoid in pregnancy

Clonidine

0.1 - 0.3 mg PO q12 scheduled; For hypertensive emergency, 0.2 mg x1, then 0.1 mg q1 hr PRN, max 0.6 mg total

α-2 agonist, BP effects within 30-60 min after PO dose Reduced CNS sympathetic flow, decreasing SVR, HR, BP; no renal blood flow changes; tolerance/tachyphylaxis develop quickly


Hydralazine

10 - 20 mg slow IV/IM bolus q4-6 hr PRN, max 40 mg/dose

Peripheral vasodilator, with fall in BP beginning within 30 min, lasting 2-4 hrs Decrease in DBP > SBP; has increased HR, stroke volume and cardiac outpt; preferential vasodilation > venodilation


By Disease

Aortic Dissection

  • Rapidly reduce sys BP to 100-120; HR 60-80 within 20min
  • Adequate analgesia will decrease sympathetic drive and assist with BP and HR control
  • Avoid volume depletion
  • Prevent reflex tachycardia
    • Labetalol alone
    • Nitroprusside or nicardipine AFTER metoprolol or esmolol

Pulmonary Edema

  • Reduce BP by 20-30%
  • Promote diuresis AFTER vasodilation

ACS

  • No more than 20-30% reduction for SBP >160
  • Consider NTG, beta-blocker

Cocaine/Amphetamine Toxicitiy

  • Benzos
  • Mixed α + B blockade
    • Phentolamine OR nitroprusside AND β-blocker

Renal Failure

  • Reduce BP by no more than 20%
  • Avoid nitroprusside (renal metabolism)
  • Labetalol or nicardipine

Eclampsia/Pre-eclampsia

  • Goal BP <160/110
  • Labetalol or nicardipine
  • Magnesium

Hypertensive emergency

CVA

Pheochromocytoma

  • Phentolamine OR (nitroprusside AND β-blocker)

Disposition

  • Admit
    • Patients receiving titratable antihypertensive therapies will likely require admission to critical care unit

See Also

External Links

References

  1. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension. 2003;42(6):1206-1252. doi:10.1161/01.HYP.0000107251.49515.c2
  2. Cienki JJ, DeLuca LA. Agreement between emergency medical services and expert blood pressure measurements. J. Emerg Med. 2012;43(1):64-68.
  3. Levy PD. Hypertensive Emergencies — On the Cutting Edge. EMCREG - International. 2011. 19-26.
  4. 2013 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC Task Force for the Management of Arterial Hypertension. J Hypertens. 2013;31(10):1925-1938.
  5. Elliott WJ. Clinical features in the management of selected hypertensive emergencies. Prog Cardiovasc Dis. 2006;48(5):316-325. doi:10.1016/j.pcad.2006.02.004
  6. Acute Stroke Practice Guidelines for Inpatient Management of Ischemic Stroke and Transient Ischemic Attack (TIA) https://www.heart.org/idc/groups/heart-public/@wcm/@private/@hcm/documents/downloadable/ucm_309996.pdf